<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0500">
 <label>100</label>
 <element-citation publication-type="journal" id="sbref0500">
  <person-group person-group-type="author">
   <name>
    <surname>Angelidou</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Diray-Arce</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Conti</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Smolen</surname>
    <given-names>K.K.</given-names>
   </name>
   <name>
    <surname>Van Haren</surname>
    <given-names>S.D.</given-names>
   </name>
   <name>
    <surname>Dowling</surname>
    <given-names>D.J.</given-names>
   </name>
  </person-group>
  <article-title>BCG as a case study for precision vaccine development: lessons from vaccine heterogeneity, trained immunity, and immune ontogeny</article-title>
  <source>Front Microbiol</source>
  <volume>11</volume>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.3389/fmicb.2020.00332</pub-id>
 </element-citation>
</ref>
